• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Ambu

Anonymous board for Ambu
Replies
2
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
4
Views
1K
anonymous
Replies
6
Views
2K
anonymous
Replies
47
Views
24K
anonymous
Replies
11
Views
7K
anonymous